2.67
-0.04(-1.48%)
Currency In USD
| Previous Close | 2.71 |
| Open | 2.76 |
| Day High | 2.76 |
| Day Low | 2.61 |
| 52-Week High | 6.2 |
| 52-Week Low | 1.33 |
| Volume | 22,177 |
| Average Volume | 382,895 |
| Market Cap | 28.44M |
| PE | -2.7 |
| EPS | -0.99 |
| Moving Average 50 Days | 2.89 |
| Moving Average 200 Days | 2.51 |
| Change | -0.04 |
If you invested $1000 in NeurAxis, Inc. (NRXS) since IPO date, it would be worth $445 as of December 07, 2025 at a share price of $2.67. Whereas If you bought $1000 worth of NeurAxis, Inc. (NRXS) shares 1 year ago, it would be worth $908.16 as of December 07, 2025 at a share price of $2.67.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
NeurAxis Secures Veterans Affairs Federal Supply Schedule Contract, Broadening Access to More Patients with Functional Abdominal Pain
GlobeNewswire Inc.
Dec 01, 2025 12:00 PM GMT
CARMEL, Ind., Dec. 01, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for chronic and debilitating conditions in children and adult
NeurAxis Announces New Medical Policy Coverage in Michigan, Adding 566,000 Covered Lives
GlobeNewswire Inc.
Nov 12, 2025 1:00 PM GMT
CARMEL, Ind., Nov. 12, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for chronic and debilitating conditions in children and adult
NeurAxis to Host Third Quarter 2025 Results and Business Update Call on Tuesday, November 11, 2025
GlobeNewswire Inc.
Nov 04, 2025 1:30 PM GMT
Financial results to be released before market open; Conference call to be conducted at 9:00 a.m. Eastern TimeCARMEL, Ind., Nov. 04, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology